A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. [electronic resource]
Producer: 20020326Description: 259-65 p. digitalISSN:- 0167-594X
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- adverse effects
- Brain Neoplasms -- diagnosis
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- Dacarbazine -- adverse effects
- Disease Progression
- Female
- Humans
- Lung Neoplasms
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Survival Analysis
- Temozolomide
- Tomography, X-Ray Computed
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.